目录:MedChemExpress LLC>>生化试剂>> Blarcamesine hydrochloride | MCE
CAS | 195615-84-0 | 纯度 | 99.87% |
---|---|---|---|
分子量 | 317.85 | 分子式 | C₁₉H₂₄ClNO |
供货周期 | 现货 | 规格 | 5 mg |
货号 | HY-101864 | 应用领域 | 医疗卫生,化工,生物产业,制药/生物制药 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 195615-84-0
产品活性:Blarcamesine hydrochloride (Anavex 2-73) is a Sigma-1 Receptor agonist with an IC50 of 860 nM.
研究领域:Neuronal Signaling
作用靶点:Sigma Receptor
In Vivo: The pre-administration of Blarcamesine leads to a dose-dependent attenuation of the scopolamine induced alternation deficit, significant at 1 and 3 mg/kg. The pre-treatment with Blarcamesine hydrochloride attenuates the impairments of step-through latency, dose dependently and significantly at doses higher than 0.3 mg/kg. The Blarcamesine hydrochloride treatment dose-dependently blocks the recognition memory deficit, with a significant effect measured at 1 mg/kg. One day after injections, the significant Aβ25-35-induced decrease in Akt phosphorylation is significantly attenuated by Blarcamesine hydrochloride at 0.1 and 1 mg/kg dose. Seven days after injections, Blarcamesine hydrochloride attenuates the decrease in Ser9 phosphorylation induced by the peptide at 0.3 and 1 mg/kg. The Blarcamesine hydrochloride treatment dose-dependently prevents the Aβ25-35-induced increase in Aβ1-42 content, with a significant effect at the highest dose tested.
相关产品:Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Neuronal Signaling Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Drug Repurposing Compound Library | Neuroprotective Compound Library | Anti-Parkinson's Disease Compound Library | Neurodegenerative Disease-related Compound Library | Targeted Diversity Library | Rare Diseases Drug Library | Antidepressant Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Sigma-LIGAND-1 hydrochloride | BD1063 dhydrochloride | EST73502 | SKF 83959 hydrobromide | NE-100 hydrochloride | Sigma-1 receptor antagonist 3 | 4-PPBP maleate | Glycerol phenylbutyrate | Opipramol | SR-31747 free base | PD 144418 oxalate | (Rac)-E1R | BMY 14802 | σ1 Receptor/μ Opioid receptor modulator 1 | Panamesine | BMY-14802 hydrochloride | PB28 | Dimemorfan phosphate | EST64454 hydrochloride | Sigma-1 receptor antagonist 1 | Phenyltoloxamine | Pentoxyverine | Ditolylguanidine | DuP 734 | Siramesine hydrochloride | Blarcamesine
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种*仅有化合物库,我们致力于为*科研客户提供前沿的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药 Patent 收录了MCE客户的科研成果;
• 专业团队跟踪新的制药及生命科学研究进展,为您提供*新的活性化合物;
• 与世界各大制药公司及*科研机构建立了长期的合作。